イベント
2026 9月 29 – 01 日
BIOSPAIN
Bilbao, Spain

Bronze Sponsor
Participation in four roundtables:
- Making ATMPs sustainable in 2026: What gets funded, scaled, and acquired? | September 29, 4:00 – 4:45 PM | VIVEbiotech speaker: Jon Alberdi, CEO.
- From platform to patient: Scaling biotech and advanced therapies through integrated CDMO ecosystems | September 30, 11:30 AM–12:15 PM | VIVEbiotech speaker: Natalia Elizalde, PhD, Chief Business Development Officer.
- From science to thew market: The value of engineering across the biotech product lifecycle | September 30, 12:15 – 1 PM | VIVEbiotech speaker: Diego Bochoeyer, Chief Operating Officer.
- Gipuzkoa facing the future of biotechnology: challenges, opportunities and strategy | September 30, 2:30 – 3:15 PM | VIVEbiotech speaker: Jon Alberdi, CEO.
- Current innovation trends in therapeutic technologies and modalities: What is the potential of spain to ride these waves? | September 30, 3:15 – 4:00 PM | VIVEbiotech speaker: Gurutz Linazasoro, MD, Founder and Board Member.
2026 9月 07 – 09 日
Advanced Therapies Europe
Barcelona, Spain

Exhibitor, booth 56
Bronze Sponsor
Panel Leadership – From Early Development to Commercial Readiness: Real-World Lessons in Advancing Lentiviral-Based Therapies | September 09, 1:30 PM – 2:30 PM
Moderator: Patricio Massera, President & Board Member, VIVEbiotech.
Speakers:
- Natalia Elizalde, PhD. Chief Business Development Officer, VIVEbiotech.
- Miguel Forte, MD, PhD. CEO, Kiji Therapeutics.
- Willem-Jan Krebber, Mbiotech, MSc, Chief Development Officer, Genewity Holding B.V.
2026 5月 11 – 15 日
ASGCT Annual Meeting
Boston, USA

Exhibitor, booth 1619
Company Presentation Shaping the Future of Lentiviral Vector Manufacturing: Versatile Platforms for Ex Vivo and In Vivo Applications, May 12, 4 PM
Sponsored Symposium by Sartorius A Collaborative Approach to Enabling Efficient LV Manufacturing for Ex Vivo and In Vivo Gene Therapies, May 12, 4:30 PM








































